St. Jude gets FDA warning for improper promotion of ablation system
The U.S. Food and Drug Administration sent a warning letter to St. Jude Medical Inc. (NYSE: STJ) that cites the device maker for improperly promoting a cardiac-ablation system. St. Jude on its website promoted its Epicor cardiac-ablation system for use in treating atrial fibrillation, an irregular heartbeat that can result in stroke. However, the system […]